Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

NuVasive 2Q net income jumps on sales boost

July 27, 2010 2:45 pm | by The Associated Press | News | Comments

NuVasive Inc. said Tuesday that its second-quarter net income surged on a boost in sales of surgical systems. The medical device maker also raised its earnings guidance for the year.The company said it earned $6.7 million, or 17 cents per share, up from $2.8 million, or 7 cents per share,...

Reform of primary care could reduce diagnostic errors

July 27, 2010 12:33 pm | by Baylor College of Medicine | News | Comments

Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant,...

TOPICS:

Fluxion Biosciences wins R & D 100 award for the IonFlux HT System

July 27, 2010 11:35 am | by I-Micronews | News | Comments

Fluxion Biosciences, a leading provider of functional cell analysis systems for drug discovery and diagnostics, announced that it has won a 2010 R&D 100 Award for its IonFlux? HT System.

Advertisement

Kinetic Concepts 2Q net income falls on costs

July 27, 2010 10:45 am | by The Associated Press | News | Comments

Medical technology company Kinetic Concepts Inc. said Tuesday its second-quarter net income fell 8 percent because of administrative and other costs.Company shares slid fell $1.31, or 3.6 percent, to $35.36 in afternoon trading. The stock has traded between $30.23 and $53.01 over the last 52...

Carbon nanotubes at heart of new system to cool 'power electronics'

July 27, 2010 10:38 am | by I-Micronews | News | Comments

Researchers have shown that an advanced cooling technology being developed for high-power electronics in military and automotive systems is capable of handling roughly 10 times the heat generated by conventional computer chips.

Silicon photonics experts set up EU cluster

July 27, 2010 10:38 am | by I-Micronews | News | Comments

Ten European consortia working on silicon photonics join forces to help transfer technology to electronics industry.

Antigenics advances herpes vaccine

July 27, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Antigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine.

Minn.-based 3M settles Wis. air-pollution charges

July 27, 2010 9:45 am | by The Associated Press | News | Comments

Wisconsin officials say 3M Co. has agreed to pay $150,000 to settle allegations of air-pollution violations at its Prairie du Chien (doo SHEEN') facility.The state attorney general's office said Tuesday the company had modified an air-pollution source without a required permit. The office also...

Advertisement

Safety Tips for Laboratorians: How Laboratorians Can Safely Calculate Workload for FDA-Approved Semi-Automated Gynecologic Cytology Screening Devices

July 27, 2010 9:36 am | by U.S. Food & Drug Administration | News | Comments

The purpose of this communication is to clarify for laboratories how workload should be calculated when using currently FDA-approved semi-automated gynecologic cytology screening devices. This communication is intended for cytotechnologists, technical...

Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals

July 27, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J. , July 27 /- James M. Golubieski , president of Foundation Venture Capital Group, LLC, (FVCG) a New Jersey Health Foundation/Foundation of UMDNJ affiliate, announced today that it has sold its equity interest in Longevica Pharmaceuticals, Inc., to Rostock International...

TOPICS:

Axela acquires Xceed Molecular

July 27, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Xceed Molecular, based in Toronto and Wellesley, has been acquired by Anaheim, Calif., based Axela Inc. which plans to provide clinical researchers with a suite of products for enhanced analysis of proteins, pathogens, DNA and RNA.

TOPICS:

BD Board of Directors Elects Christopher Jones

July 27, 2010 8:34 am | by Becton, Dickinson and Company | News | Comments

(July 26, 2010) -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it has elected Christopher Jones to its Board of Directors, effective today.  Mr. Jones, 55, is the former Chief Executive Of

TOPICS:

Mindray to Attend the 2010 American Association for Clinical Chemistry Conference

July 27, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China , July 27 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it will attend the 2010 American Association for Clinical Chemistry (AACC) conference in...

TOPICS:

Moffitt Cancer Center and CvergenX, Inc. Sign Licensing Agreement

July 27, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

TAMPA, Fla. , July 27 /- Moffitt Cancer Center and CvergenX, Inc. , announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™....

TOPICS:

O.I. Corporation Announces Third Quarter Dividend

July 27, 2010 7:45 am | by The Associated Press | News | Comments

O.I. Corporation (NASDAQ: OICO) today announced that its Board of Directors declared a quarterly cash dividend of $0.05 per common share payable on August 30, 2010 to shareholders of record at the close of business on August 13, 2010.About O.I. Corporation:O.I. Corporation, dba OI Analytical,...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading